You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence

Drug combination delays worsening of disease in women with recurrent ovarian cancer

September 10, 2014

Researchers from the Susan F. Smith Center for Women’s Cancers at Dana-Farber report that for some women with recurrent ovarian cancer, a new drug combination has been found to stall the progression of the disease.

Yawkey Center for Cancer Care 

U.S. News and World Report ranks Dana-Farber/Brigham and Women’s Cancer Center the top cancer hospital in New England; fourth in U.S.

U.S. News and World Report ranks Dana-Farber/Brigham and Women's Cancer Center the top hospital in New England for the 14th straight year.
 

Matthew Meyerson, MD, PhD in the lab 

Nineteen Dana-Farber scientists listed among world's most influential

In an affirmation of worldwide respect for the impact of Dana-Farber research, 19 basic scientists and clinical investigators at the Institute have been listed among "the world's most influential scientific minds." The ranking was based on how frequently their research discoveries have been cited by peers in the past decade.
 

ASCO issues new guideline on treating patients with advanced, HER2-negative breast cancer
September 03, 2014

The American Society of Clinical Oncology (ASCO) today issued a new clinical practice guideline on chemotherapy and targeted therapy for women with HER2-negative advanced breast cancer. The guideline provides detailed, evidenced-based information on the efficacy and side effects of various therapies.

Dana-Farber Cancer Institute receives national certification for highest quality cancer care
September 02, 2014

The Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), has awarded Dana-Farber Cancer Institute a three-year certification for outpatient hematology-oncology practices that meet its highest standards for quality cancer care.

Early detection and transplantation provide best outcomes for bubble boy disease
July 31, 2014

Children born with so-called “bubble boy” disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years published in the New England Journal of Medicine. The researchers say the findings argue for expanding newborn screening for the life-threatening immune disorder.

Drug combination delays worsening of disease in women with recurrent ovarian cancer (Health Canal)

September 11, 2014

A clinical trial led by Dr. Ursula Matulonis and Dr. Joyce Liu showed a two-drug combination can signficantly improve benefit for women with ovarian cancer that has recurred after initial treatment.

 

Should Women Remove Breasts and Ovaries Because of Future Cancer Risk? (Healthline.com)
September 15, 2014

Dr. Harold Burstein commented on a study that found there was no evidence that surgery lowered the risk of death compared to more conservative lumpectomy and radiation.

 

End-of-life Care Preferences: A Promising Target for Reducing Racial Disparities in Terminal Cancer Care (HealthCanal.com)
September 12, 2014

Shannon Harrington, PhD, participated in a study showing a patient's race and ethnicity dramatically influenced their preferences about the care they receive at the end of their lives.

 

The Transformation (The New Yorker magazine)
September 11, 2014

Dr. William Kaelin commented on the cancer-stem-cell model, and the possibility of controlling cancer without killing it.

 

Cancer leaves a common fingerprint on DNA (Oncology Nurse Advisor)
September 10, 2014

Rafael Irizarry, PhD, co-led a new study investigating all stages and types of cancers that appear to share a telltale signature of widespread changes to the epigenome.

 

Curt Schilling Returning to ESPN in Studio Role After Battling Cancer (Boston Globe)
September 10, 2014

Former Red Sox pitcher and Dana-Farber patient Curt Schilling announced he will return to ESPN as a studio analyst after he took a leave of absence following his cancer diagnosis.

 

A child saved becomes a teen hunting for cures (Boston Globe)
September 08, 2014

Former Dana-Farber/Boston Children’s Cancer and Blood Disorders Center patient Kate Franklin spent the summer interning in the lab of Dr. Loren Walensky, who treated her for leukemia when she was a child.
 

Holy Name Parish Blood Drive

September 20, 2014

9:00 AM - 3:00 PM

Parish Hall, 525 West Roxbury Parkway, West Roxbury, MA 02132

To schedule an appointment for this drive, please contact Kevin Shea at kevinshea114@gmail.com. more

Stage IV Breast Cancer Support Group(2)

September 22, 2014

11:00 AM - 12:30 PM

Smith Building, Room 335

An opportunity for those with stage IV (metastatic) breast cancer to share emotional support.  Registration is required.  Please call Liz Farrell at 617-632-5606 for more information and to register. more

Brain Tumor Support Group(4)

September 22, 2014

1:30 PM - 3:00 PM

Smith Building, Room 335

Support for brain tumor patients and their caregivers. Facilitated by Debra LaFrankie and nancy Tharler.  Registration is required.  Please call 617-632-3634 for more information and to register. more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    For children:
    888-733-4662


    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2014-2015 logo    U.S. News Best Children's Hospitals Cancer 2014-2015 logo 

    Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer

  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now